Literature DB >> 26181073

Hepatic sinusoidal obstruction associated with S-1 plus cisplatin chemotherapy for highly advanced gastric cancer with paraaortic lymph node metastases: report of a case.

Hirofumi Toi1, Yosuke Miura2, Susumu Shibasaki3, Kenji Chisaka2, Manabu Goto2, Ichiro Tsuda3, Takahisa Nakamura3, Taiji Hase3.   

Abstract

A 56-year-old man who was diagnosed with gastric cancer with multiple paraaortic lymph node metastases was treated with S-1 plus cisplatin. The spleen gradually enlarged during the therapeutic courses. After the 6th course of therapy, the primary gastric lesion and paraaortic lymphadenopathies disappeared. He underwent a curative resection, including a distal gastrectomy with regional and paraaortic lymph node dissections. Irregularly distributed congestion of the liver was noted during the surgery. Histological examinations revealed residual cancer cells in 3 regional lymph nodes and no cancer cells in the primary site and paraaortic lymph nodes. Hepatic sinusoidal obstruction syndrome (SOS) was also confirmed histologically. This is the first report of a case with SOS after S-1 plus cisplatin therapy. S-1 plus cisplatin therapy can cause SOS, although it is a promising preoperative chemotherapy for highly advanced gastric cancer.

Entities:  

Keywords:  Drug liver injury; Neoadjuvant chemotherapy; Oral fluoropyrimidines; Splenomegaly; Veno-occlusive disease

Year:  2012        PMID： 26181073     DOI： 10.1007/s12328-012-0333-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN： 1865-7265


  24 in total

1.  Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.

Authors:  K Inoue; Y Nakane; M Kogire; K Fujitani; Y Kimura; H Imamura; S Tamura; S Okano; A H Kwon; Y Kurokawa; T Shimokawa; H Takiuchi; T Tsujinaka; H Furukawa
Journal:  Eur J Surg Oncol       Date:  2011-12-09       Impact factor: 4.424

Review 2.  Hepatobiliary complications of hematopoietic cell transplantation, 40 years on.

Authors:  George B McDonald
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

3.  Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a case.

Authors:  M Iwahashi; M Nakamori; M Tani; H Yamaue; S Sakaguchi; M Nakamura; K Ueda; M Ichiro; E Nishino; H Tanimura
Journal:  Oncology       Date:  2001       Impact factor: 2.935

4.  Characterization of a reproducible rat model of hepatic veno-occlusive disease.

Authors:  L D DeLeve; R S McCuskey; X Wang; L Hu; M K McCuskey; R B Epstein; G C Kanel
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

5.  Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.

Authors:  Michael J Overman; Dipen M Maru; Chusilp Charnsangavej; Evelyn M Loyer; Huamin Wang; Priyanka Pathak; Cathy Eng; Paulo M Hoff; Jean-Nicolas Vauthey; Robert A Wolff; Scott Kopetz
Journal:  J Clin Oncol       Date:  2010-04-20       Impact factor: 44.544

6.  Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial.

Authors:  Jaffer A Ajani; Wuilbert Rodriguez; Gyorgy Bodoky; Vladimir Moiseyenko; Mikhail Lichinitser; Vera Gorbunova; Ihor Vynnychenko; August Garin; Istvan Lang; Silvia Falcon
Journal:  J Clin Oncol       Date:  2010-02-16       Impact factor: 44.544

7.  Pathological complete response of synchronous multiple liver metastases associated with advanced gastric cancer to gastrectomy and prompt S-1 treatment in combination with fractional cisplatin: report of a case.

Authors:  Souya Nunobe; Takashi Kiyokawa; Fumihiko Hatao; Ikuo Wada; Nobuyuki Shimizu; Sachiyo Nomura; Yoshihiro Mise; Yasuhiko Sugawara; Norihiro Kokudo; Yasuyuki Seto
Journal:  Hepatogastroenterology       Date:  2012 Jan-Feb

8.  Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.

Authors:  Thomas Aloia; Mylène Sebagh; Marylène Plasse; Vincent Karam; Francis Lévi; Sylvie Giacchetti; Daniel Azoulay; Henri Bismuth; Denis Castaing; René Adam
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

9.  Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.

Authors:  Hiroshi Nakano; Elie Oussoultzoglou; Edoardo Rosso; Selenia Casnedi; Marie-Pierre Chenard-Neu; Patrick Dufour; Philippe Bachellier; Daniel Jaeck
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

10.  Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

Authors:  Gunnar Folprecht; Thomas Gruenberger; Wolf O Bechstein; Hans-Rudolf Raab; Florian Lordick; Jörg T Hartmann; Hauke Lang; Andrea Frilling; Jan Stoehlmacher; Jürgen Weitz; Ralf Konopke; Christian Stroszczynski; Torsten Liersch; Detlev Ockert; Thomas Herrmann; Eray Goekkurt; Fabio Parisi; Claus-Henning Köhne
Journal:  Lancet Oncol       Date:  2009-11-26       Impact factor: 41.316
View more
  1 in total

1.  Peripheral hepatic sinusoidal obstruction syndrome due to oxaliplatin-based chemotherapy.

Authors:  Shinichiro Kobayashi; Sadayuki Okudaira; Kazuma Kobayashi; Kengo Kanetaka; Susumu Eguchi
Journal:  Clin Case Rep       Date:  2019-01-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.